Kozak & Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37K Hold
16
﹤0.01% 371
2026
Q1
$1.36K Hold
16
﹤0.01% 380
2025
Q4
$1.12K Hold
16
﹤0.01% 385
2025
Q3
$1.04K Hold
16
﹤0.01% 405
2025
Q2
$1.24K Hold
16
﹤0.01% 369
2025
Q1
$975 Hold
16
﹤0.01% 389
2024
Q4
$903 Hold
16
﹤0.01% 382
2024
Q3
$948 Hold
16
﹤0.01% 351
2024
Q2
$842 Hold
16
﹤0.01% 346
2024
Q1
$896 Hold
16
﹤0.01% 352
2023
Q4
$725 Hold
16
﹤0.01% 343
2023
Q3
$795 Hold
16
﹤0.01% 364
2023
Q2
$919 Hold
16
﹤0.01% 334
2023
Q1
$953 Hold
16
﹤0.01% 323
2022
Q4
$1K Hold
16
﹤0.01% 319
2022
Q3
$1K Hold
16
﹤0.01% 312
2022
Q2
$1K Hold
16
﹤0.01% 352
2022
Q1
$1K Hold
16
﹤0.01% 362
2021
Q4
$1K Hold
16
﹤0.01% 362
2021
Q3
$1K Buy
+16
New +$692 ﹤0.01% 315

Other funds holding CTVA

Kozak & Associates's CTVA Position: Q2 2026 in Review

Kozak & Associates held its Corteva (CTVA) position steady in Q2 2026 at 16 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Kozak & Associates first reported a position in CTVA in Q3 2021 and has held it in 20 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Kozak & Associates held 16 shares of Corteva worth $1.37K as of Q2 2026.
  • Kozak & Associates left its Corteva share count unchanged in Q2 2026.
  • Corteva made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #371 holding.
  • Kozak & Associates first reported a position in Corteva in Q3 2021 and has held it in 20 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.